Sectors
US firm PaxVax scores USD22 million in Series B for late-stage cholera vaccine
California-based pharmaceutical company PaxVax Inc raised USD22 million in a Series B funding round for the late-stage trial of its single-dose oral cholera vaccine for travelers.
TDR Capital to exit 8% stake in British life insurer Phoenix Group
Private equity firm TDR Capital will sell half of its entire stake in insurance company Phoenix Group for about GBP127 million. TDR will sell 18 million shares out of its total 35.9 million shares in Phoenix.
Student loan on the rise, varies by region -report
A study by The Institute for College Access and Success found that America's class of 2012 graduated with an average of USD29,400 in student loan debt. Student debt levels, however, varies according to state and geographical regions.
Cambridge fat-burning drug maker Zafgen nabs USD45 million in Series E funding
Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.